These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16720809)

  • 1. Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
    Luborzewski A; Regen F; Schindler F; Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):248-9. PubMed ID: 16720809
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe mania complicating treatment of narcolepsy with cataplexy.
    Crosby MI; Bradshaw DA; McLay RN
    J Clin Sleep Med; 2011 Apr; 7(2):214-6. PubMed ID: 21509339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone as an antidote to venlafaxine-induced bruxism.
    Jaffee MS; Bostwick JM
    Psychosomatics; 2000; 41(6):535-6. PubMed ID: 11110119
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 6. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
    Dallal A; Chouinard G
    J Clin Psychopharmacol; 1998 Aug; 18(4):343-4. PubMed ID: 9690703
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 8. Buspirone to improve compliance in venlafaxine-induced movement disorder.
    Pavlovic ZM
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):523-4. PubMed ID: 15383159
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine plus venlafaxine in treatment-resistant depression.
    Devarajan S; Dursun SM
    J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultra short manic-like episodes after antidepressant augmentation with modafinil.
    Fountoulakis KN; Siamouli M; Panagiotidis P; Magiria S; Kantartzis S; Iacovides A; Kaprinis GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):891-2. PubMed ID: 18068287
    [No Abstract]   [Full Text] [Related]  

  • 11. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
    Liau CH; Shen WW; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):121-2. PubMed ID: 16472373
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizures associated with venlafaxine, methylphenidate, and zolpidem.
    Tavakoli SA; Gleason OC
    Psychosomatics; 2003; 44(3):262-4. PubMed ID: 12724513
    [No Abstract]   [Full Text] [Related]  

  • 14. An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.
    Reznik I; Rosen Y; Rosen B
    J Psychopharmacol; 1999; 13(2):193-5. PubMed ID: 10475726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of venlafaxine and imipramine in depressive illness.
    Rajagopalan M
    Acta Psychiatr Scand; 1998 May; 97(5):384-5. PubMed ID: 9611090
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual and coenesthetic hallucinations associated with modafinil.
    Oulis P; Kouzoupis AV; Kontoangelos K; Pachou E; Masdrakis VG; Soldatos CR
    J Clin Psychopharmacol; 2008 Apr; 28(2):251-2. PubMed ID: 18344746
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious adverse events and the modafinil augmentation study.
    Block J
    CNS Spectr; 2006 May; 11(5):340; author reply 340-2. PubMed ID: 16791971
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium augmentation of venlafaxine in adolescent major depression.
    Walter G; Lyndon B; Kubb R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):457-9. PubMed ID: 9672738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 20. Venlafaxine and the rapid development of anasarca.
    Ballon JS; Schulman MC
    J Clin Psychopharmacol; 2006 Feb; 26(1):97-8. PubMed ID: 16415719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.